Thomas Schinecker
Vorstandsvorsitzender bei ROCHE HOLDING AG
Vermögen: 661 932 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Severin Schwan | M | 57 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 16 Jahre |
Sean Johnston | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Hans Clevers | M | 67 | 5 Jahre | |
Richard P. Lifton | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 9 Jahre |
Levi Garraway | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 Jahre |
Joerg Duschmale | M | 40 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 4 Jahre |
Albert Bourla | M | 62 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Alan Hippe | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 Jahre |
Claudia Dyckerhoff | M | 58 | 8 Jahre | |
Patrick Frost | M | 56 | 4 Jahre | |
Aviv Regev | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Akiko Iwasaki | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Bernard Poussot | M | 72 | 9 Jahre | |
Anita Hauser | F | 55 | 7 Jahre | |
André S. Hoffmann | M | 66 | 28 Jahre | |
Teresa Graham | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Silke Hörnstein | F | 49 | 9 Jahre | |
Ed Harrington | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Jemilah Mahmood | M | - | - | |
Axel Radlach Pries | M | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | 7 Jahre |
Claudia Boeckstiegel | F | 60 | 4 Jahre | |
Andrea Grebe | M | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | 7 Jahre |
Quita Highsmith | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Astrid Lurati | F | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | 7 Jahre |
Detlev Corsepius | M | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | - |
Nina Beikert | F | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | - |
Tim Brown | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Cristina A. Wilbur | F | 57 | - | |
Pascale Schmidt | F | 51 | 4 Jahre | |
Cori Davis | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 2 Jahre |
Richard Locksley | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Peggy Han | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Annette Luther | M | 54 | 4 Jahre | |
Antonio Esteve Cruella | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Sabine Borngräber | F | - | - | |
Paola Ricci | F | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Ian Read | M | 71 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Stefan Oschmann | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Hans Jörg Reinhardt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 14 Jahre |
Ulf Mark Schneider | M | 59 | - | |
Olivier Brandicourt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Lana Dubovik | F | - |
New York University
| 22 Jahre |
Tapan Durgadas Ray | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Jorge Gallardo Ballart | M | 82 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 20 Jahre |
Bruno Eschli | M | - | - | |
Ugo di Francesco | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Beatrice Hau | F | - | - | |
Nicolas Dunant | M | - | - | |
Sunao Manabe | M | 69 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 1 Jahre |
Roger Connor | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Alexander Zehnder | M | 54 | - | |
Barbara Schadler | F | 62 | 5 Jahre | |
Max Starkov | M | - |
New York University
| 23 Jahre |
Ulf Arne Wiinberg | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Birgit Masjost | M | - | - | |
Dieter Weinand | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Ashley Magargee | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Andreas Oeri | M | 75 | 24 Jahre | |
Erich Hunziker | M | 70 | 10 Jahre | |
Lodewijk J. R. de Vink | M | 78 | 9 Jahre | |
Walter Frey | M | 80 | 10 Jahre | |
Cheryl Mills | F | 59 |
New York University
| 7 Jahre |
John Bell | M | 71 | 19 Jahre | |
DeAnne Shirley Julius | M | 75 | 14 Jahre | |
Young Min Ban | M | - |
New York University
| 4 Jahre |
Domenico Scala | M | 59 | 8 Jahre | |
William Burns | M | 76 | 4 Jahre | |
Julie Brown | F | 62 | 6 Jahre | |
John Beczak | M | - |
New York University
| 3 Jahre |
Dora Lee | F | - |
New York University
| 6 Jahre |
Beatrice Weder di Mauro | M | 57 | 10 Jahre | |
Thomas Cueni | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 7 Jahre |
Ajar Ashyrkulova | M | - |
New York University
| 5 Jahre |
Bob Silverman | M | - | 27 Jahre | |
Pamela Kaufman | F | - |
New York University
| 4 Jahre |
Paul Bulcke | M | 69 | 11 Jahre | |
Bruno Gehrig | M | 77 | 9 Jahre | |
Wolfgang Ruttenstorfer | M | 73 | 4 Jahre | |
Christoph Franz | M | 64 | 12 Jahre | |
Pius Baschera | M | 73 | 10 Jahre | |
Kristine F. Treglia | F | - |
New York University
| 5 Jahre |
Peter Voser | M | 64 | 8 Jahre | |
Gottlieb A. Keller | M | 70 | 28 Jahre | |
Arthur Levinson | M | 73 | - | |
Fritz Gerber | M | 95 | - | |
Manish Rajguru | M | - |
New York University
| 2 Jahre |
Tim Oshea | M | - |
New York University
| 4 Jahre |
Chase Cho | M | - |
New York University
| 7 Jahre |
Matthew Epstein | M | - |
New York University
| 4 Jahre |
May Gando | F | - |
New York University
| 4 Jahre |
Christopher Burger | M | - |
New York University
| 4 Jahre |
Jodi Kovitz | F | - |
New York University
| 3 Jahre |
Alyssa Klapper | F | - |
New York University
| 1 Jahre |
Daniel Roever | M | - |
New York University
| 2 Jahre |
Ke Lu | M | 48 |
New York University
| 1 Jahre |
Kirsta Anderson | F | 45 |
New York University
| 4 Jahre |
Will Griggs | M | - |
New York University
| 4 Jahre |
david jar | M | - |
New York University
| 4 Jahre |
Jordan Hoffner | M | 53 |
New York University
| 2 Jahre |
Rebecca Raphael | F | - |
New York University
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 80 | 80,00% |
Schweiz | 16 | 16,00% |
Deutschland | 5 | 5,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Thomas Schinecker
- Persönliches Netzwerk